BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20393380)

  • 21. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
    Marra CM
    Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syphilis and neurosyphilis: HIV-coinfection and value of diagnostic parameters in cerebrospinal fluid.
    Merins V; Hahn K
    Eur J Med Res; 2015 Oct; 20():81. PubMed ID: 26445822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of neurosyphilis in human immunodeficiency virus-infected individuals.
    Tomberlin MG; Holtom PD; Owens JL; Larsen RA
    Clin Infect Dis; 1994 Mar; 18(3):288-94. PubMed ID: 8011805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurosyphilis: Concordance between cerebrospinal fluid analysis and subsequent antibiotic strategy for patients undergoing evaluation of a diagnosis of neurosyphilis.
    Smibert OC; Abbinga S; Spelman DW; Jenney AWJ
    Int J Infect Dis; 2019 May; 82():73-76. PubMed ID: 30853444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis?
    Davis AP; Stern J; Tantalo L; Sahi S; Holte S; Dunaway S; Marra CM
    Clin Infect Dis; 2018 Jan; 66(3):363-367. PubMed ID: 29020214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis.
    Dersch R; Hottenrott T; Senel M; Lehmensiek V; Tumani H; Rauer S; Stich O
    Fluids Barriers CNS; 2015 May; 12():12. PubMed ID: 25975424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.
    Lukehart SA; Hook EW; Baker-Zander SA; Collier AC; Critchlow CW; Handsfield HH
    Ann Intern Med; 1988 Dec; 109(11):855-62. PubMed ID: 3056164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical prediction and diagnosis of neurosyphilis in HIV-infected patients with early Syphilis.
    Dumaresq J; Langevin S; Gagnon S; Serhir B; Deligne B; Tremblay C; Tsang RS; Fortin C; Coutlée F; Roger M
    J Clin Microbiol; 2013 Dec; 51(12):4060-6. PubMed ID: 24088852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Treponema pallidum-Specific Opsonic Antibody Activity in HIV-Infected Patients With Syphilis.
    Marra CM; Tantalo LC; Sahi SK; Dunaway SB; Lukehart SA
    J Infect Dis; 2016 Apr; 213(8):1348-54. PubMed ID: 26655298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurosyphilis in HIV-infected patients.
    Bordón J; Martínez-Vázquez C; Alvarez M; Miralles C; Ocampo A; de la Fuente-Aguado J; Sopeña-Perez Arguelles B
    Eur J Clin Microbiol Infect Dis; 1995 Oct; 14(10):864-9. PubMed ID: 8605899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Criteria for the diagnosis of neurosyphilis in cerebrospinal fluid: relationships with intrathecal immunoglobulin synthesis and blood-cerebrospinal fluid barrier dysfunction.
    Levchik N; Ponomareva M; Surganova V; Zilberberg N; Kungurov N
    Sex Transm Dis; 2013 Dec; 40(12):917-22. PubMed ID: 24220351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study.
    Lu Y; Ke W; Yang L; Wang Z; Lv P; Gu J; Hao C; Li J; Cai Y; Gu M; Liu H; Chen W; Zhang X; Wang L; Liu Y; Yang B; Zou H; Zheng H
    BMC Infect Dis; 2019 Dec; 19(1):1017. PubMed ID: 31791265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cerebrospinal fluid enzyme immunoassay for diagnosis of neurosyphilis.
    Chan Y; Yeung KH; Ho HF; Ho KM; Tin-Keung Lam E; Leung WL; Kam KM
    Int J STD AIDS; 2014 Jul; 25(8):571-8. PubMed ID: 24334293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of neurosyphilis in HIV-positive patients diagnosed with early syphilis.
    Firlag-Burkacka E; Swiecki P; Cielniak I; Siwak E; Gizinska J; Bakowska E; Kubicka J; Pulik P; Kowalski J; Podlasin R; Horban A
    HIV Med; 2016 May; 17(5):323-6. PubMed ID: 27089861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of
    Yang L; Fu Y; Li S; Liu C; Liu D
    Infect Drug Resist; 2022; 15():7791-7798. PubMed ID: 36600952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibitory factor as a novel cerebrospinal fluid marker for neurosyphilis among HIV-negative patients.
    Lin LR; Lin DH; Tong ML; Liu LL; Fan JY; Zhu XZ; Gao K; Chen MJ; Zheng WH; Zhang HL; Li SL; Lin HL; Lin ZF; Niu JJ; Yang TC
    Clin Chim Acta; 2016 Dec; 463():103-108. PubMed ID: 27751728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.
    Marra CM; Maxwell CL; Smith SL; Lukehart SA; Rompalo AM; Eaton M; Stoner BP; Augenbraun M; Barker DE; Corbett JJ; Zajackowski M; Raines C; Nerad J; Kee R; Barnett SH
    J Infect Dis; 2004 Feb; 189(3):369-76. PubMed ID: 14745693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurosyphilis: from infection to autoinflammation?
    Drago F; Javor S; Parodi A
    Int J STD AIDS; 2016 Mar; 27(4):327-8. PubMed ID: 26873161
    [No Abstract]   [Full Text] [Related]  

  • 39. Towards a refined understanding of cerebrospinal fluid CXCL13 in neurosyphilis diagnosis among people with HIV.
    de S Carvalho R; Rangel IC; Ferry FRA
    AIDS; 2024 Jul; 38(8):1275-1278. PubMed ID: 38814719
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of antiretroviral therapy is associated with higher risk of neurosyphilis among HIV-infected patients who remain serofast after therapy for early syphilis.
    Pastuszczak M; Sitko M; Bociaga-Jasik M; Kucharz J; Wojas-Pelc A
    Medicine (Baltimore); 2018 Nov; 97(45):e13171. PubMed ID: 30407349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.